About Acetylcholine receptor subunit beta
Acetylcholine receptor subunit beta (CHRNB1) is a protein
from Homo sapiens identified by UniProt accession
P11230, 501 residues long.
MolForge cross-references it against 0 known binders and
136 disease associations.
Target properties
| Protein name | Acetylcholine receptor subunit beta |
| UniProt accession | P11230 |
| Gene | CHRNB1 |
| Organism | Homo sapiens |
| Length | 501 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (136)
Diseases linked to this target (Open Targets).
- Congenital myasthenic syndromes · score 0.79
- post-operative sign or symptom · score 0.58
- pain · score 0.55
- acute respiratory distress syndrome · score 0.53
- pregnancy · score 0.50
- severe acute respiratory syndrome · score 0.50
- intracranial hypertension · score 0.46
- rotator cuff tear · score 0.46
- morbid obesity · score 0.46
- oxidative stress · score 0.46
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P11230-F1 | alphafold | PREDICTED | 79.46 | — |
Amino-acid sequence (501 residues)
MTPGALLMLL GALGAPLAPG VRGSEAEGRL REKLFSGYDS SVRPAREVGD RVRVSVGLIL AQLISLNEKD EEMSTKVYLD LEWTDYRLSW DPAEHDGIDS LRITAESVWL PDVVLLNNND GNFDVALDIS VVVSSDGSVR WQPPGIYRSS CSIQVTYFPF DWQNCTMVFS SYSYDSSEVS LQTGLGPDGQ GHQEIHIHEG TFIENGQWEI IHKPSRLIQP PGDPRGGREG QRQEVIFYLI IRRKPLFYLV NVIAPCILIT LLAIFVFYLP PDAGEKMGLS IFALLTLTVF LLLLADKVPE TSLSVPIIIK YLMFTMVLVT FSVILSVVVL NLHHRSPHTH QMPLWVRQIF IHKLPLYLRL KRPKPERDLM PEPPHCSSPG SGWGRGTDEY FIRKPPSDFL FPKPNRFQPE LSAPDLRRFI DGPNRAVALL PELREVVSSI SYIARQLQEQ EDHDALKEDW QFVAMVVDRL FLWTFIIFTS VGTLVIFLDA TYHLPPPDPF P
Explore Acetylcholine receptor subunit beta with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets